Regenerx Biopharm OTC Stock Forward View
| RGRX Stock | USD 0.0003 0.00 0.00% |
Regenerx OTC Stock outlook is based on your current time horizon.
At this time the value of rsi of Regenerx Biopharm's share price is below 20 indicating that the otc stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Regenerx Biopharm based on different types of headlines from major news networks to social media. Using Regenerx Biopharm hype-based prediction, you can estimate the value of Regenerx Biopharm In from the perspective of Regenerx Biopharm response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Regenerx Biopharm In on the next trading day is expected to be -0.02 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.58. Regenerx Biopharm after-hype prediction price | USD 3.25E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Regenerx |
Regenerx Biopharm Additional Predictive Modules
Most predictive techniques to examine Regenerx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regenerx using various technical indicators. When you analyze Regenerx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Regenerx Biopharm Naive Prediction Price Forecast For the 1st of February
Given 90 days horizon, the Naive Prediction forecasted value of Regenerx Biopharm In on the next trading day is expected to be -0.02 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0003, and the sum of the absolute errors of 0.58.Please note that although there have been many attempts to predict Regenerx OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Regenerx Biopharm's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Regenerx Biopharm OTC Stock Forecast Pattern
| Backtest Regenerx Biopharm | Regenerx Biopharm Price Prediction | Buy or Sell Advice |
Regenerx Biopharm Forecasted Value
In the context of forecasting Regenerx Biopharm's OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Regenerx Biopharm's downside and upside margins for the forecasting period are 0.000003 and 14.26, respectively. We have considered Regenerx Biopharm's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Regenerx Biopharm otc stock data series using in forecasting. Note that when a statistical model is used to represent Regenerx Biopharm otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.8583 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0094 |
| MAPE | Mean absolute percentage error | 33.3601 |
| SAE | Sum of the absolute errors | 0.576 |
Predictive Modules for Regenerx Biopharm
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regenerx Biopharm. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Regenerx Biopharm After-Hype Price Density Analysis
As far as predicting the price of Regenerx Biopharm at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regenerx Biopharm or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Regenerx Biopharm, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Regenerx Biopharm Estimiated After-Hype Price Volatility
In the context of predicting Regenerx Biopharm's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regenerx Biopharm's historical news coverage. Regenerx Biopharm's after-hype downside and upside margins for the prediction period are 0.00 and 14.28, respectively. We have considered Regenerx Biopharm's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Regenerx Biopharm is out of control at this time. Analysis and calculation of next after-hype price of Regenerx Biopharm is based on 3 months time horizon.
Regenerx Biopharm OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Regenerx Biopharm is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regenerx Biopharm backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regenerx Biopharm, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.80 | 14.28 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0003 | 0.0003 | 8.33 |
|
Regenerx Biopharm Hype Timeline
Regenerx Biopharm is at this time traded for 0.0003. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Regenerx is projected to increase in value after the next headline, with the price projected to jump to 3.25E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is projected to be 8.33%, whereas the daily expected return is at this time at -0.8%. The volatility of related hype on Regenerx Biopharm is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has return on total asset (ROA) of (0.8397) % which means that it has lost $0.8397 on every $100 spent on assets. This is way below average. Regenerx Biopharm's management efficiency ratios could be used to measure how well Regenerx Biopharm manages its routine affairs as well as how well it operates its assets and liabilities. Given the investment horizon of 90 days the next projected press release will be within a week. Check out Historical Fundamental Analysis of Regenerx Biopharm to cross-verify your projections.Regenerx Biopharm Related Hype Analysis
Having access to credible news sources related to Regenerx Biopharm's direct competition is more important than ever and may enhance your ability to predict Regenerx Biopharm's future price movements. Getting to know how Regenerx Biopharm's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regenerx Biopharm may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BSYI | Biosyntech | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NBIO | Nascent Biotech | 0.00 | 0 per month | 29.45 | 0.17 | 150.00 | (76.74) | 1,099 | |
| HMGN | Hemagen Diagnostics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CHNXF | ChitogenX | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 590.91 | |
| QRON | Qrons Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DRWN | Quantum Medical Transport | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VDRM | Viaderma | 0.00 | 0 per month | 17.21 | 0.18 | 100.00 | (33.33) | 225.00 | |
| FFNTF | 4Front Ventures Corp | 0.00 | 0 per month | 0.00 | 0.18 | 1,000.00 | (100.00) | 1,100 | |
| RASP | Rasna Therapeutics | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 87.50 | |
| FORZ | Forza Innovations | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Regenerx Biopharm
For every potential investor in Regenerx, whether a beginner or expert, Regenerx Biopharm's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Regenerx OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Regenerx. Basic forecasting techniques help filter out the noise by identifying Regenerx Biopharm's price trends.Regenerx Biopharm Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Regenerx Biopharm otc stock to make a market-neutral strategy. Peer analysis of Regenerx Biopharm could also be used in its relative valuation, which is a method of valuing Regenerx Biopharm by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Regenerx Biopharm Market Strength Events
Market strength indicators help investors to evaluate how Regenerx Biopharm otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regenerx Biopharm shares will generate the highest return on investment. By undertsting and applying Regenerx Biopharm otc stock market strength indicators, traders can identify Regenerx Biopharm In entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 3.0E-4 | |||
| Day Typical Price | 3.0E-4 | |||
| Relative Strength Index | 0.0625 |
Story Coverage note for Regenerx Biopharm
The number of cover stories for Regenerx Biopharm depends on current market conditions and Regenerx Biopharm's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regenerx Biopharm is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regenerx Biopharm's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Additional Tools for Regenerx OTC Stock Analysis
When running Regenerx Biopharm's price analysis, check to measure Regenerx Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenerx Biopharm is operating at the current time. Most of Regenerx Biopharm's value examination focuses on studying past and present price action to predict the probability of Regenerx Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenerx Biopharm's price. Additionally, you may evaluate how the addition of Regenerx Biopharm to your portfolios can decrease your overall portfolio volatility.